A novel immunogenic cell death–related subtype classification and risk signature for predicting prognosis and immunotherapy efficacy in gastric cancer

The majority of gastric cancer (GC) patients are in a progressive stage at the initial stage of treatment, and the overall response rate to immunotherapy remains unsatisfactory largely due to the lack of effective prognostic biomarkers. Immunogenic cell death (ICD) was identified as a new form of re...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Bingqi, Wu, Yingchao, Zhang, Junling, Gu, Yanlun, Xie, Ran, He, Xu, Pang, Xiaocong, Wang, Xin, Cui, Yimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196197/
https://www.ncbi.nlm.nih.gov/pubmed/37215130
http://dx.doi.org/10.3389/fimmu.2023.1162876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196197/
https://www.ncbi.nlm.nih.gov/pubmed/37215130
http://dx.doi.org/10.3389/fimmu.2023.1162876

Ejemplares similares